Duyvendak M, Naunton M, van Roon E N, Bruyn G A W, Brouwers J R B J
Department of Pharmacotherapy and Pharmaceutical Care, University of Groningen, Ant. Deusinglaan 1, 9713 AV, Groningen, The Netherlands.
Osteoporos Int. 2008 Oct;19(10):1379-94. doi: 10.1007/s00198-008-0598-y. Epub 2008 Jul 16.
Corticosteroid-induced osteoporosis (CIOP) is currently undertreated. Systematic review of the literature revealed that the percentage of patients treated adequately is dependent on study quality. Therefore, it remains unknown whether adherence to the guidelines is really so poor. Five major quality criteria provide the standard for future studies on this scope.
It has recently been stated that the degree of prophylaxis of corticosteroid-induced osteoporosis (CIOP) is low and effort should be put into determining reasons for non-prescribing of preventive agents. The aim of this study was to identify: how many studies adequately audit the prevalent guideline; the longitudinal trends in prevention of CIOP; which patient groups appear to be most undertreated; and which intervention strategies are effective.
We performed a comprehensive search of MEDLINE and systematically recorded the outcomes and quality of published studies, using five major criteria.
Twenty-four studies were included in the analysis. The quality of the included studies was poor (31%) or moderate (37%). There was a longitudinal increase in quality of the studies and percentage of prevention. Multivariable linear regression showed that the quality of the study was the only independent predictor of the prevention rate reported in the study.
The results show undertreatment of CIOP might be due to insufficient quality of the studies rather than poor practice or failure to recognise the right patients. Future interventions should comply with five major quality criteria, and a multifaceted approach is required in order to make an impact on the underprescribing of CIOP prophylaxis.
目前,糖皮质激素性骨质疏松症(CIOP)的治疗不足。对文献的系统评价显示,接受充分治疗的患者比例取决于研究质量。因此,目前尚不清楚对指南的遵循情况是否真的如此糟糕。五项主要质量标准为今后该领域的研究提供了规范。
最近有研究指出,糖皮质激素性骨质疏松症(CIOP)的预防程度较低,应努力确定未开具预防药物的原因。本研究的目的是确定:有多少研究充分审核了现行指南;CIOP预防的纵向趋势;哪些患者群体似乎治疗最不足;以及哪些干预策略是有效的。
我们对MEDLINE进行了全面检索,并使用五项主要标准系统记录了已发表研究的结果和质量。
24项研究纳入分析。纳入研究的质量较差(31%)或中等(37%)。研究质量和预防比例呈纵向上升趋势。多变量线性回归显示,研究质量是研究中报告的预防率的唯一独立预测因素。
结果表明,CIOP治疗不足可能是由于研究质量不足,而非实践不佳或未识别出合适的患者。未来的干预措施应符合五项主要质量标准,并且需要采取多方面的方法,以便对CIOP预防药物处方不足产生影响。